|
gptkbp:instanceOf
|
synthetic cannabinoid
|
|
gptkbp:agonist_of
|
gptkb:CB1_receptor
gptkb:CB2_receptor
|
|
gptkbp:CASNumber
|
gptkb:112601-51-9
|
|
gptkbp:category
|
gptkb:benzochromenes
phenols
cannabinoids
|
|
gptkbp:chemicalFormula
|
C25H38O3
|
|
gptkbp:developedBy
|
gptkb:Hebrew_University
gptkb:Raphael_Mechoulam
|
|
gptkbp:discoveredBy
|
1988
|
|
gptkbp:hasSMILES
|
CC(C)(CCCCCC)C1=CC2=C(C3=C(CCC(C3)C2O1)CO)O
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
HU-210
|
|
gptkbp:isomerOf
|
gptkb:HU-211
|
|
gptkbp:IUPACName
|
gptkb:(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
|
|
gptkbp:legal_status_in_UK
|
Class B drug
|
|
gptkbp:legalStatus
|
Schedule I controlled substance
|
|
gptkbp:molecularWeight
|
386.57 g/mol
|
|
gptkbp:potency
|
100–800 times more potent than THC
|
|
gptkbp:PubChem_CID
|
104865
|
|
gptkbp:relatedTo
|
gptkb:CP_55,940
gptkb:WIN_55,212-2
gptkb:JWH-018
gptkb:HU-211
|
|
gptkbp:routeOfAdministration
|
oral
inhalation
intraperitoneal injection
|
|
gptkbp:UNII
|
6QK0F9N1TB
|
|
gptkbp:bfsParent
|
gptkb:JWH-018
gptkb:CNR1
|
|
gptkbp:bfsLayer
|
7
|